Literature DB >> 11808827

Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.

Mark S Wallace1, Beri Ridgeway, Albert Leung, Gery Schulteis, Tony L Yaksh.   

Abstract

The authors have extended preclinical studies on pain to human volunteers by examining the effects of intravenous alfentanil and ketamine on acute sensory thresholds andfacilitated processing induced by intradermal capsaicin. Eleven healthy subjects received targeted plasma concentrations of alfentanil, ketamine, and placebo followed by neurosensory testing (thermal and von Frey hair thresholds). After completing the tests at the highest plasma level, intradermal capsaicin was injected into the volar aspect of the left forearm, and the flare response and hyperalgesia to von Frey hair, stroking, and heat were assessed. Alfentanil significantly elevated cool and warm thresholds and decreased capsaicin-induced stroking hyperalgesia. Ketamine significantly decreased capsaicin-induced von Frey hair hyperalgesia. Both drugs resulted in a significant elevation of von Frey hair-induced pain thresholds and a decrease in capsaicin-induced pain. These studies suggest that experimental human pain models may be used to study analgesic pharmacology and may serve as important methods for defining the analgesic efficacy of drugs in phase I clinical trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11808827     DOI: 10.1177/0091270002042001008

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  9 in total

1.  Effect of Intravenous Alfentanil on Nonpainful Thermally Induced Hyperalgesia in Healthy Volunteers.

Authors:  Carolyn Schifftner; Gery Schulteis; Mark S Wallace
Journal:  J Clin Pharmacol       Date:  2017-05-02       Impact factor: 3.126

Review 2.  Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 3.  A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models.

Authors:  Guido van Amerongen; Matthijs W de Boer; Geert Jan Groeneveld; Justin L Hay
Journal:  Br J Clin Pharmacol       Date:  2016-07-08       Impact factor: 4.335

Review 4.  Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 5.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy.

Authors:  Ruth Ruscheweyh; Oliver Wilder-Smith; Ruth Drdla; Xian-Guo Liu; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2011-03-28       Impact factor: 3.395

6.  Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems.

Authors:  John F Peppin; Phillip J Albrecht; Charles Argoff; Burkhard Gustorff; Marco Pappagallo; Frank L Rice; Mark S Wallace
Journal:  Pain Ther       Date:  2015-01-28

7.  Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study.

Authors:  Pascal H Vuilleumier; Marie Besson; Jules Desmeules; Lars Arendt-Nielsen; Michele Curatolo
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

8.  Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.

Authors:  Aude Castel; Pierre Hélie; Francis Beaudry; Pascal Vachon
Journal:  BMC Vet Res       Date:  2013-03-27       Impact factor: 2.741

9.  The effect of acupuncture needle combination on central pain processing--an fMRI study.

Authors:  Albert Leung; Yi Zhao; Shivshil Shukla
Journal:  Mol Pain       Date:  2014-03-25       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.